Recent evidence supports, in particular, the role of zingerone supplementation as chemopreventive agent, reducing cancer incidence in dimethyl hydrazine treated rats; the mechanism included the inhibition of cell proliferation, the induction of cell apoptosis, and the suppression of NF-κB and heme oxygenase (HO)-1 expression [70]. Here, NFKB1 is linked to cancer.